Bruce Car - 03 Oct 2022 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
Chief Scientific Officer
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
BHVN
Transactions as of
03 Oct 2022
Net transactions value
$0
Form type
4
Filing time
05 Oct 2022, 17:40:53 UTC
Previous filing
05 Oct 2022
Next filing
06 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to Buy) Award $0 +300,000 $0.000000 300,000 03 Oct 2022 Common Shares 300,000 $7.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date.